Surai Thaneemit Jones, M.S.
SUMMARY OF QUALIFICATIONS
** ***** ** ******** ***** experience: special expertise in binary and longitudinal outcomes.
9 years of experience managing teams of technical and administrative staff.
Therapeutic areas include cardiology, oncology, genetics and mental health.
Programming experience in SAS and R/S+ (20 years) and handling complex and large data structures.
Independent Statistical Consultant
2006-present Palo Alto, CA
Medical Device Start-Ups
Strategic advisor to VP of Clinical Affairs.
Advise on trial design strategies including primary endpoint selection and adaptive design methods.
Create statistical reports for FDA submissions.
Review and edit sections of protocol, technical reports.
Healthcare Research Organizations (affiliates of Stanford University)
Published outcomes research articles as lead statistician, write statistical methodology sections of grant proposals.
Advised teams on research plans, develop statistical methodologies, explore methodologies.
Directed teams of programmers to analyze large archival datasets in SAS.
Create and validate statistical programs, publication-ready tables and graphics using STATA, R, SPSS and SAS.
Revised trial submission to achieve approval to conduct clinical trial for bipolar disorder.
Lead Biostatistician Cooperative Studies Program Coordinating Center (CSPCC)
2003-2006 Department of Veterans Affairs
Menlo Park, CA
Managed multiple teams to conduct clinical trials in chronic heart failure, prostate cancer and mental health.
Participated as Lead Biostatistician:
Achieved approval for pivotal phase III prostate cancer trial.
Led startup and conduct of two 30- site clinical trials.
Co-developed standards for analysis and data management for a Beta-Blocker study.
Collaborated with Statisticians from Stanford University to publish journal articles.
Supervised alls tasks performed by Statistical Programmers and Data Managers.
Improved design of new clinical trials to be submitted for merit and funding approval.
Mentored by Chief of CSPCC/Department Head of Biostatistics, Stanford University.
Coordinated extended team:
Managed 3 teams of Biostatisticians, Health Economists, Pharmacists, Clinicians, Data Managers, Statistical Programmers and Project Managers.
Established project deadlines to ensure timely deliverables for each member of study team.
Hired and supervised Statistical Programmers and Data Managers including daily task assignment, training, mentoring, and monitoring on-going performance.
Hired and coached team of 6 Administrative Assistants.
Participated in management-level policy meetings regarding center-wide issues.
Senior Statistical Programmer Cooperative Studies Coordinating Center
1996-2002 Department of Veterans Affairs
Menlo Park, CA
Supervised team of 4 Statistical Programmers and 2 Database Programmers in a phase III chronic heart failure trial.
Taught mini-courses in data management and statistical analysis using SAS.
Generated clinical data reports for Data and Safety Monitoring Board meetings and FDA submissions.
Co-developed programming and documentation standards for center-wide use.
M.S. Biostatistics Medical College of Virginia 1996
B.S. Mathematics Salisbury University 1994
The Beta-Blocker Evaluation of Survival Trial (BEST) Investigators: The Effect of -Adregergic Blockade on Mortality in Patients With Advanced Chronic Heart Failure. New England Journal of Medicine, 344:1659-1667, 2001.
Aranda J, Krause-Steinrauf H, Greenberg B, Heng M, Kosolcharoen P, Renlund D, Thaneemit-Chen S, White M, Cintron G, for the BEST Investigators. Effect of Beta-Blockade with Bucindolol in Elderly Patients with Heart Failure. American Journal of Cardiology, 89:1322-1326, 2002.
Bristow M, Krause-Steinrauf H, Abraham W, Liang C-S, Hattler B, Kruger S, Lindenfeld J, Lowes BD, Olson L, Thaneemit S, Zelis R. Sympatholytic effect of bucindolol adversely affected survival, and was disproportionately observed in the class IV subgroup of BEST. Circulation, 104:740-755, 2001.
Lindenfeld J, Ghali J, Adams K, Goldman S, Khan S, Peberdy M, Thaneemit-Chen S, Rosenberg Y, Yancy C, Young J, Krause-Steinrauf H, for the BEST Investigators. Hormone Replacement Therapy Predicts Outcome in Women with Advanced Heart Failure. Journal of the American College of Cardiology, 42:1238-45, 2003.
Bristow MR, Robertson AD, Lavori P, Thaneemit-Chen S, Small KM, Liggett SB. α2C-Adrenergic receptor 322-325 DEL polymorphism enhanced the sympatholytic effect of bucindolol, and adversely affected clinical outcomes in the BEST Trial. Circulation, 112:340-351, 2005.
Buxbaum J, Jacobson DR, Tagoe C, Alexander A, Kitzman DW, Greenberg B, Thaneemit-Chen S, Lavori P. Transthyretin. V122I in African Americans with congestive heart failure. Journal of the American College of Cardiology, 7(8):1724-5, 2006.
Liggett S; Mialet-Perez J; Thaneemit-Chen S; Weber S; Greene S; Hodne D; Nelson B; Morrison J; Domanski M; Wagoner L; Abraham W; Anderson J; Carlquist J; Krause-Steinrauf H; Lazzeroni L; Port J; Lavori P; Bristow M. A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure. Proceedings of the National Academy of Sciences of the United States of America,103(30):11288-93, 2006.
McFall M; Saxon A; Thaneemit-Chen S et al.. Integrating smoking cessation into mental health care for post-traumatic stress disorder. Clinical trials, 4(2):178-89, 2007.
Montgomery B; Lavori P; Garzotto M; Lee K; Brophy M; Thaneemit-Chen S; Kelly W; Basler J; Ringer R; Yu W; Whittemore A; Lin D. Veterans Affairs Cooperative Studies Program study 553: Chemotherapy after prostatectomy, a phase III randomized study of prostatectomy versus prostatectomy with adjuvant docetaxel for patients with high-risk, localized prostate cancer. Urology, 72(3):474-80, 2008.
Weitlauf JC, Finney JW, Ruzek JI, Lee TT, Thrailkill A, Jones S, Frayne SM. Distress and Pain During Pelvic Examinations: Effect of Sexual Violence. Obstetrics and Gynecology, 112: 6: 1343-1350, 2008.
Weitlauf JC, Frayne SM, Finney JW, Moos RH, Jones S, Hu K, Spiegel D. Sexual violence, posttraumatic stress disorder, and the pelvic examination: how do beliefs about the safety, necessity, and utility of the examination influence patient experiences? J Womens Health (Larchmt). 2010 Jul;19(7):1271-80.
Judith Chapman, Megan Oser, Jill Hockemeyer, Julie Weitlauf, Surai Jones and Ramsey Cheung. Changes in Depressive Symptoms and Impact on Treatment Course Among Hepatitis C Patients Undergoing Interferon-α and Ribavirin Therapy: A Prospective Evaluation. The American Journal of Gastroenterology, (in press 9 August 2011)